Research powered investment banking
Home
Research
Companies
Find Alpha
Themes
Top Picks
Premium
Transactions
Events
Redeye
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Members network
Community
sign in
Log in
Sign up
Home
research
Companies
Find Alpha
Themes
Top Picks
Transactions
Events
redeye
About
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Community
The latest from Redeye about Scandinavian Life Science and Technology companies
Vicore Pharma Holding
A First POC in Covid-19
Nanologica
Confirmation of Progress
Premium
Life Science Outlook 2021
Replay from Jan 19th
Orexo
Zubsolv solidly maintains market share
Sensys Gatso Group
Impressive recruitment
PowerCell Sweden
BlackRock almost at 10%
Premium
Strax
Goda framtidsutsikter för STRAX
Redeye Life Science Outlook 2021
Analysts’ Top Picks
Better Collective
Betting and Regulatory Tailwind
Orexo
Change of policy positive for Zubsolv